Flavia Borellini
Director/Board Member at REVOLUTION MEDICINES, INC.
Net worth: 375 381 $ as of 2024-04-29
Network origin in Flavia Borellini first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 25 | |
| Public Company | Biotechnology | 25 | |
| Public Company | Pharmaceuticals: Other | 23 | |
20
| Public Company | Pharmaceuticals: Major | 20 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.
20
| Subsidiary | Pharmaceuticals: Major | 20 |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland.
7
| Subsidiary | Real Estate Development | 7 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands.
6
| Subsidiary | Pharmaceuticals: Generic | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Flavia Borellini via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal President Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Corporate Officer/Principal Chairman | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Corporate Officer/Principal Director/Board Member Undergraduate Degree Masters Business Admin | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Founder Chief Executive Officer | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Founder | |
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member Chief Executive Officer Chief Executive Officer | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Human Resources Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Founder Corporate Officer/Principal Director/Board Member | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Chairman Founder Chief Executive Officer | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| EQRX, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Founder | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Imperial College London | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SERES THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Roche Deutschland Holding GmbH
 Roche Deutschland Holding GmbH Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Deutschland Holding GmbH is a German company that manufactures and distributes pharmaceutical products. The company is based in Grenzach-Wyhlen, Germany. The CEOs are Claudia Fleischer, Hagen Pfundner, Ulrich Winkel. The company was founded in 1997 by Fritz Hoffmann-La Roche. Roche Deutschland Holding was acquired by NEXUS AG on November 30, 2018. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
The State Bar of California
 The State Bar of California Miscellaneous Commercial ServicesCommercial Services The State Bar of California operates as an official attorney licensing agency. The non-profit company is based in San Francisco, CA. Elizabeth Rindskopf Parker has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Altrubio, Inc.
 Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Internet Retail | Director/Board Member Director/Board Member | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
| University of San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Corporate Officer/Principal General Counsel | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| ACTIVE BIOTECH AB | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| GERON CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistics
International
| United States | 45 |
| Sweden | 4 |
| Switzerland | 2 |
| United Kingdom | 2 |
| Germany | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Finance | 3 |
| Health Services | 3 |
Operational
| Director/Board Member | 503 |
| Corporate Officer/Principal | 244 |
| Independent Dir/Board Member | 175 |
| Chairman | 126 |
| Chief Executive Officer | 88 |
Most connected contacts
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Neil Exter | 33 |
| William Ringo | 32 |
| Thomas Wiggans | 31 |
| Ivor Royston | 30 |
| Roger Pomerantz | 30 |
| Iain Dukes | 30 |
| José Baselga | 27 |
| Gottlieb A. Keller | 26 |
| Alexis Borisy | 25 |
| Peter Svennilson | 25 |
| Elizabeth Anderson | 24 |
| Pablo Cagnoni | 24 |
| Wendell Wierenga | 23 |
| Severin Schwan | 23 |
- Stock Market
- Insiders
- Flavia Borellini
- Company connections
